Clinical Trial Update: A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating regadenoson for stress myocardial perfusion imaging comparing multidetector CT to SPECT in coronary artery disease; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Coronary Artery Disease (CAD) | Phase 2 | Status: COMPLETED | Results posted: 2013-09-18